Article

Usefulness of Monitoring Circulating Tumor Cells as a Therapeutic Biomarker in Melanoma with BRAF Mutation

2020-10-09

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Circulating tumor cells (CTCs) are non-invasive biomarkers that could be used to characterize changes in tumors. In this study, we monitored the number of CTCs, as well as the <italic>BRAF</italic> genotype of individual CTCs. <bold>Methods: </bold>CTCs were isolated from peripheral blood using a high-density dielectrophoretic microwell array, followed by labeli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2841f7cf-eaf3-5f82-9c4e-11e0190b7a88
DOI: 10.21203/rs.3.rs-88937/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Usefulness of Monitoring Circulating Tumor Cells as a Therapeutic Biomarker in Melanoma with BRAF MutationDOI 10.21203/rs.3.rs-88937/v1Read

Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cellsSemantic proximity Read

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma PatientsSemantic proximity Read

Future of circulating tumor cells in the melanoma clinical and research laboratory settings.Semantic proximity Read

Clinical significance of <scp>BRAF</scp> mutation status in circulating tumor <scp>DNA</scp> of metastatic melanoma patients at baselineSemantic proximity Read

Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome ProfilesSemantic proximity Read

Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumorsSemantic proximity Read

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level.Semantic proximity Read

Clinical utility of a blood-based BRAF(V600E) mutation assay in melanoma.Semantic proximity Read

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.Semantic proximity Read

Characterising the phenotypic evolution of circulating tumour cells during treatment.Semantic proximity Read

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.Semantic proximity Read

Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.Semantic proximity Read